CRC Research Update — June 26, 2026
Today's colorectal cancer research highlights
ctdna
A collection of 99 issues
CRC Research Update — June 20, 2026
Today's colorectal cancer research highlights
Blood-based DNA methylation test shows promise for early detection
Skip to content
The CRC Digest
Blood-based DNA methylation test shows promise for early detection
A pilot study of 50 participants in Gaza evaluated circulating tumor DNA methylation biomarkers (SEPT9, SPG20, ALX4, MGMT, and RASSF1A) for non-invasive colorectal cancer detection, with multi-gene panels showing improved diagnostic performance. (Clinica Chimica Acta)
CRC Research Update — June 18, 2026
Today's colorectal cancer research highlights
CRC Research Update — June 09, 2026
Today's colorectal cancer research highlights
CRC Research Update — June 07, 2026
Today's colorectal cancer research highlights
CRC Research Update — June 06, 2026
Today's colorectal cancer research highlights
CRC Research Update — June 04, 2026
Today's colorectal cancer research highlights
This Week in CRC Research — May 31, 2026
Weekly colorectal cancer research intelligence
Prior anti-EGFR therapy affects HER2-targeted treatment outcomes
Skip to content
The CRC Digest
▸ TREATMENT
Prior anti-EGFR therapy affects HER2-targeted treatment outcomes — ESMO Open
An integrated analysis of the TRIUMPH and MyPathway studies examined how prior treatment with anti-EGFR (epidermal growth factor receptor) therapy affects the effectiveness of pertuzumab plus trastuzumab in HER2-amplified metastatic colorectal cancer. The study